• 19 Feb 24
 

Anglo American PLC - Anglo American Platinum year end results 2023

Anglo American plc | AAL | 2,680 8.0 0.3% | Mkt Cap: 31,578m


 
RNS Number : 5020D
Anglo American PLC
19 February 2024
 

19 February 2024

Anglo American plc notification:

Anglo American Platinum Limited year end results 2023

 

Anglo American plc ("Anglo American") notes Anglo American Platinum Limited's announcement of its results for the year ended 31 December 2023, released this morning to the Johannesburg Stock Exchange and available via the following website link: www.angloamericanplatinum.com/investors/financial-results-centre.

 

Anglo American Platinum Limited reported adjusted EBITDA of R24.4 billion (audited), equivalent to approximately $1.3 billion.

 

Below is a reconciliation of Anglo American Platinum Limited's adjusted EBITDA to its contribution to Anglo American's underlying EBITDA:

 

 

US$ billion

 

2023

Anglo American Platinum Limited reported adjusted EBITDA(1)


~1.3

Adjustments for corporate cost allocation and other items

 

~ (0.1)

Contribution to Anglo American underlying EBITDA (not audited)

 

~1.2

 

(1)   Adjusted EBITDA as disclosed in Anglo American Platinum Limited's annual report, defined as earnings before interest, tax, depreciation and amortisation adjusted to exclude scrapping of assets and the related insurance claim income, profit on sale of assets and remeasurements of loans and receivables.

 

Anglo American will report results for the year ended 31 December 2023 on 22 February 2024. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Legal Entity Identifier: 549300S9XF92D1X8ME43

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCSFIFMMELSESE

Research Tree RNS Article

To continue viewing this RNS article, please advise if you are one of the following:

Return to News Summary